Three New Square

Thomas Hinchliffe QC

Current View:

This content is provided by Thomas Hinchliffe QC.

Practice Areas

All aspects of contentious intellectual property, with a particular emphasis on patent litigation in the pharmaceutical, biotechnology and mobile telephony fields. Recent notable cases include: MSD v Wyeth [2020]; Conversant v Huawei [2020]; Aspire & Accord v Allergan [2019]; Emson v Hozelock [2020] & [2019]; Philips v Asus [2018]; Generics v Yeda [2017]; Merck v Comptroller [2017]; Illumina v Premaitha [2017]; Merck v Teva [2017], Novartis v Actavis [2016]; Lilly v Actavis [2016]; Hospira v Cubist [2017 & 2016]; Unwired Planet v Samsung [2016]; Merck v Ono [2015]; Synthon v Teva [2015]; Vringo v ZTE [2014]; Philips v Nintendo [2014]; HTC v Nokia [2014]; Samsung v Apple [2013]; Generics v Yeda [2012]; Merck v Sigma [2012]; Warner- Lambert v Teva [2011]; Datacard v Eagle Technologies [2011]; Abbott v Medinol [2010]; RIM v Motorola [2010]; Scinopharm v Eli Lilly [2009]; Generics UK v Daiichi [2009]; Actavis v Merck [2008]; Generics v Lundbeck [2008]; Qualcomm v Nokia [2008]; Conor v Angiotech [2007].

Career

Called to the Bar 1997. Took silk in 2016. Editor of the 18th and 19th editions of Terrell on the Law of Patents.

Professional Memberships

Intellectual Property Bar Association; Chancery Bar Association.

Personal

Brasenose College Oxford (1995 MA, Chemistry).